purpose of reducing the deficit in the separate financial statements of the Company. 5 November 2018: U City’s ordinary and preferred shares start trading at new par value. The reverse stock split which
: Extraordinary Shareholders’ Meeting approves capital restructuring. The Extraordinary Shareholders’ Meeting (EGM) approves a series of transactions, namely (i) a reverse stock split of ordinary and preferred
preferred shares shall be 10 shares per 1 vote where any fraction of shares shall be discarded. (3) In case of any change in par value from a share split or a reverse share split, the preferred shares’ rights
prepared. DNAL Co., Ltd.’s financial statements for the period ended June 30, 2017 are disclosed herein as a comparative statement. Unit: Baht million Separate Financial Statements Fiscal Year Quarter March
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
Chiang Mai Ram Medical Business Pcl., (CMR) amount Baht 1,035.05 million. comparing at the same period in 2016 representing 11.98% increase. Income from medical treatments in the separate financial went up